The clinical performance is complex and often involves multiple systems. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathology testing.
The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. The individualized development of treatment programs related to treatment and management of HIV is often involved in drug treatment, rehabilitation prevention, and regular follow-up management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved.
Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of HL. The platform serves a team of internationally authoritative experts at home and abroad in the field of blood tumours in China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.